← Leaderboards
Hector Ramos Biliran
Xavier University Of Louisiana
$1,585,088
Attributed
$1,585,088
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $427.6K · FY2010–25$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,585,088 · 3
By mechanism
R15$790,517 · 1
R16$578,006 · 1
SC2$216,565 · 1
Top collaborators
No co-investigators on record.
Most similar at Xavier University Of Louisiana
Same institution · by research overlap
- Cheryl L Klein Stevens$3,483,570
- Beverly H Wright$22,948,651
- Mehnaaz Fatima Ali$1,675,051
- Shantoyia S Jones$369,363
- Kitani Lemieux$369,363
Others in their field
Top investigators on “Apoptotic”
- Douglas R Green · Burnham Institute For Medical Research$36,561,515
- Ira A Tabas · Columbia University Health Sciences$25,367,980
- Robert L Ferris · University Of Pittsburgh At Pittsburgh$21,268,306
- Anthony G Letai · Dana-Farber Cancer Inst$20,781,967
- Augustine M Choi · Weill Medical Coll Of Cornell Univ$19,019,183
- Loren D Walensky · Northeastern University$17,252,485
Research focus
ApoptoticProgramsOncogenesAnchorage-Independent GrowthPrincipal InvestigatorResistanceProteinsCell-Matrix JunctionAnoikisMolecularEpithelial CellsIntegrinsTumorigenicityCell LineGenetic TranscriptionSignal PathwayMediatingMalignant NeoplasmsCancer TherapyTumorigenicPhenotypeLungLung NeoplasmsOverexpression
Grant awards (8)
Role of the transcriptional corepressor TLE1 in the lung adenocarcinoma aggressiveness and progression$146,314
R16 · FY2025 · GM · contact PI
Role of the transcriptional corepressor TLE1 in the lung adenocarcinoma aggressiveness and progression$145,106
R16 · FY2024 · GM · contact PI
Role of the transcriptional corepressor TLE1 in the lung adenocarcinoma aggressiveness and progression$143,934
R16 · FY2023 · GM · contact PI
Role of the transcriptional corepressor TLE1 in the lung adenocarcinoma aggressiveness and progression$142,652
R16 · FY2022 · GM · contact PI
Bit1 as a tumor suppressor and a therapeutic target in NSCLC$427,627
R15 · FY2015 · CA · contact PI
A Role of Bit1 in the Apoptosis Resistance, Anoikis Insensitvity, and Chemoresist$362,890
R15 · FY2012 · CA · contact PI
Regulation of anoikis and transformation in human breast cancer cells by Bit1$108,559
SC2 · FY2011 · CA · contact PI
Regulation of anoikis and transformation in human breast cancer cells by Bit1$108,006
SC2 · FY2010 · CA · contact PI